Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

Impacts of antibody cross-reactivity on gut community ecology and vaccine immunogenicity

Descrizione del progetto

Vaccini contro gli agenti patogeni resistenti agli antimicrobici

La resistenza antimicrobica (AMR, antimicrobial resistance) si verifica quando i microrganismi si evolvono per resistere agli effetti esercitati dai farmaci antimicrobici; l’abuso e l’utilizzo eccessivo di tali medicinali aggravano questo fenomeno, rendendoli inefficaci e minacciando le procedure comuni di routine. I vaccini costituiscono un’opzione valida contro la resistenza antimicrobica, ma dobbiamo prima comprendere il modo in cui il sistema immunitario è in grado di distinguere tra agenti patogeni dannosi e microbi intestinali benefici. Con il sostegno del programma di azioni Marie Skłodowska-Curie, il progetto SUGAR studierà le modalità attraverso cui le risposte immunitarie agli agenti patogeni prioritari in relazione all’AMR, come Salmonella e Shigella, possono avere una reazione incrociata con i batteri intestinali utili a causa di strutture di zucchero di superficie condivise, fornendo risultati che guideranno lo sviluppo di vaccini precisi capaci di combattere l’AMR senza alterare la salute dell’intestino.

Obiettivo

Antimicrobial resistance (AMR) is a looming global threat, rendering antibiotic treatments useless, and making bacterial infections difficult to treat. With diminishing antibiotic options to control infectious outbreaks, we must develop new strategies to prevent widespread mortality. Our group develops novel vaccines to leverage the body’s natural immune responses to fight bacterial infections. To do this, it is crucial to understand how our immune systems recognize harmful bacteria (“pathogens”), and how they distinguish them from the ‘good’ gut-resident microbes which promote human health. Oral vaccines typically induce protective immune responses which recognize sugar structures on the outer membrane of harmful bacteria, promoting their elimination. However, some of these sugar structures use the same molecular building blocks as those found on the surface of beneficial bacteria. In fact, some pathogens mimic the sugar structures of beneficial microbes to evade the immune system. In turn, this may lead to inappropriate recognition of good bacteria by the immune system. I plan to combine vaccination studies in mice with molecular tools to study direct surface sugar-immune interactions, focusing on immune responses to World Health Organization AMR priority pathogens Salmonella and Shigella. I will answer fundamental questions about immune-bacterial recognition: (1) Can immune antibodies induced in response to harmful pathogens also recognize good bacteria? (2) Does this recognition impact the composition and host-beneficial functions of gut resident microbial communities? (3) Does non-specificity of bacterial immune targeting reduce vaccine-mediated protection? Outcomes will contribute to fundamental scientific knowledge of immune-bacterial interactions and provide valuable public health insights, including explaining individual variation in vaccine protectiveness. Ultimately, this work will inform the design of effective human vaccines to combat AMR.

Campo scientifico (EuroSciVoc)

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) HORIZON-MSCA-2024-PF-01

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Contributo netto dell'UE
€ 260 347,92
Indirizzo
WELLINGTON SQUARE UNIVERSITY OFFICES
OX1 2JD Oxford
Regno Unito
Regione
South East (England) Berkshire, Buckinghamshire and Oxfordshire Oxfordshire
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
Nessun dato